| 2022 |
Chu YJ, Jeng WJ, Pan MH, Hu HH, Luo WS, Su CY, Chiang CT, Jen CL, Chen CJ, (Yang HI*, Serum soluble programmed death-1 levels predict the spontaneous HBeAg seroclearance in chronic hepatitis B., JOURNAL OF GASTROENTEROLOGY, vol. 57(6), 423-432, 2022 |
| 2022 |
Hu HH, Jeng WJ, Pan MH, Luo WS, Chang CL, Huang YT, Su CY, Chiang CT, Jen CL, Chien YC, Lu SN, Wang LY, Huang LR, Lee MH, Liu J, Nguyen MH, Chen CJ, (Yang HI*, Serum soluble programmed cell death 1 levels predict spontaneous functional cure in inactive carriers with chronic hepatitis B., ALIMENTARY PHARMACOLOGY & THERAPEUTICS, vol. 55(5), 558-567, 2022 |
| 2022 |
Park J, Le AK, Tseng TC, Yeh ML, Jun DW, Trinh H, Wong GLH, Chen CH, Peng CY, Kim SE, Oh H, Kwak MS, Cheung KS, Toyoda H, Hsu YC, Jeong JY, Yoon EL, Ungtrakul T, Zhang J, Xie Q, Ahn SB, Enomoto M, Shim JJ, Cunningham C, Jeong SW, Cho YK, Ogawa E, Huang R, Lee DH, Takahashi H, Tsai PC, Huang CF, Dai CY, Tseng CH, Yasuda S, Kozuka R, Li J, Wong C, Wong CC, Zhao C, Hoang J, Eguchi Y, Wu C, Tanaka Y, Gane E, Tanwandee T, Cheung R, Yuen MF, Lee HS, Yu ML, Kao JH, (Yang HI, Nguyen MH, Progression Rates by Age, Sex, Treatment, and Disease Activity by AASLD and EASL Criteria: Data for Precision Medicine., CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, vol. 20(4), 874-885, 2022 |
| 2022 |
Huang DQ, Li X, Le MH, Le AK, Yeo YH, Trinh HN, Zhang J, Li J, Wong C, Wong C, Cheung RC, (Yang HI*, Nguyen MH*, Natural History and Hepatocellular Carcinoma Risk in Untreated Chronic Hepatitis B Patients with Indeterminate Phase, CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, vol. 20(8), 1803-1812, 2022 |
| 2022 |
Wen-Juei Jeng, Mei-Hung Pan, (Hwai-I Yang*, Letter: sPD‐1 as a predictor for HBsAg seroconversion—shed light on inactive carriers with chronic hepatsitis B. Authors' reply, ALIMENTARY PHARMACOLOGY & THERAPEUTICS, vol. 55(8), 1057-1058, 2022 |
| 2022 |
Wu HC*, Jeng WJ, Pan MH, Hsieh YC, Lu SN, Chen CJ, (Yang HI*, Incidence of hepatocellular carcinoma in a community-based Taiwanese population without chronic HBV/HCV infection., JHEP Reports, vol. 4(2), 100410-doi: 10.1016/j.jhepr, 2022 |
| 2022 |
Tai AS, Huang YT, (Yang HI, Lan LV, Lin SH, G-Computation to Causal Mediation Analysis With Sequential Multiple Mediators-Investigating the Vulnerable Time Window of HBV Activity for the Mechanism of HCV Induced Hepatocellular Carcinoma., FRONTIERS IN PUBLIC HEALTH, vol. 9, 757942, 2022 |
| 2022 |
Argirion I, Brown J, Jackson S, Pfeiffer RM, Lam TK, O'Brien TR, Yu KJ, McGlynn KA, Petrick JL, Pinto LA, Chen CJ, Hildesheim A, (Yang HI, Lee MH, Koshiol J, Association between Immunologic Markers and Cirrhosis in Individuals from a Prospective Chronic Hepatitis C Cohort., Cancers, vol. 14(21), 5280-doi: 10.3390/cancers14215280, 2022 |
| 2022 |
Peng CW, Jeng WJ, (Yang HI, Liu YC, Chien RN, Liaw YF, A switch from tenofovir to entecavir prior to hepatitis B treatment cessation is associated with a reduced risk of off-therapy relapse: An observational study., JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, vol. 37(11), 2164-2172, 2022 |
| 2022 |
Wu S, Zhou J, Wu X, Sun Y, Wang B, Kong Y, Zhan S, Jia J, (Yang HI, You H, Comparative performance of 14 HCC prediction models in CHB: a dynamic validation at serial on-treatment timepoints., AMERICAN JOURNAL OF GASTROENTEROLOGY, vol. 117(9), 1444-1453, 2022 |
| 2022 |
Chi CH, (Wang YS, Ng LT*, Structural characterization of mushroom polysaccharides by cyclic ion mobility-mass spectrometry., Journal of chromatography. A, vol. 1680, 463445, 2022 |
| 2022 |
Chang Ko-Keng, Cai Yi-Hong, Hsiao Chih-Hao, Hsu Cheng-Chih, (Wang Yi-Sheng)*, High-performance miniature linear time-of-flight mass spectrometry as an advantageous tool in a high mass-to-charge range, The Analyst, vol. 147(18), 4116-4123, 2022 |
| 2022 |
Cai Yi-Hong, Lin Cheng-Huang, (Wang Yi-Sheng)*, Theoretical study of the impact of ion acceleration parameters on the mass resolving power in linear MALDI time-of-flight mass spectrometry, International Journal of Mass Spectrometry, vol. 471, 116756, 2022 |
| 2022 |
Yong Tracer, Chang Ko-Keng, (Wang Yi-Sheng, Ma Che*, Active Humoral Response Reverts Tumorigenicity through Disruption of Key Signaling Pathway, Vaccines, vol. 10(2), 163, 2022 |
| 2022 |
Lo, S.M., S.H.Hwang, C.L. Liu, (C.N. Shen, W.H. Hong, W.C. Yang, M.H. Lee, C.R.Shen, Inhibiting TLR7 Expression in the Retinal Pigment Epithelium Suppresses Experimental Autoimmune Uveitis, Frontiers in Immunology, vol. 12, 736251, 2022 |
| 2022 |
Hsu, F. C., H.L. Lee, Y.J. Chen, Y.A. Shen, M.H. Wu, W.S. Huang, Y.C. Tsai, S.D. Yeh, C.C. Kuo, L.S. Lu, (C.N. Shen*, J.F. Chiou*, A Few-Shot Learning Approach Assists in the Prognosis Prediction of Magnetic Resonance-Guided Focused Ultrasound for the Local Control of Bone Metastatic Lesions, Cancers, vol. 12, 445, 2022 |
| 2022 |
W.A. Chen, Y.H. Chen, C.Y. Hsieh, P.F. Hung, C.W. Chen, C.H. Chen, J.L. Lin, T.J. R. Cheng, T.L. Hsu, Y.T. Wu, (C.N. Shen*, W.C. Cheng*., Harnessing Natural-Product-Inspired Combinatorial Chemistry and Computation-Guided Synthesis to Develop N-Glycan Modulators as Anticancer Agents., Chemical Science, vol. 13, 6233-6243, 2022 |
| 2022 |
Khamushavalli, G., Guo, J.Y., (C.N. Shen, J.K. Jiang, C.S.J. Fann, M.J. Hwang, J.W. Shui, H.T. Lin, M.J. Wang, H.C. Shih, A. F.Y. Li, S.C. Chang, S.H. Yang*, J.Y. Chen*., Patient-derived organoids serves as a platform for personalized chemotherapy in advanced colorectal cancer patients., Frontiers in Oncology, vol. 12, 883437, 2022 |
| 2022 |
C.W. Lee, C.C. Kuo, C.J. Liang, H.J. Pan, (C.N. Shen*, C.H. Lee*, Effects of the media conditioned by various macrophage subtypes derived from THP-1 cells on tunneling nanotube formation in pancreatic cancer cells, BMC Molecular and Cell Biology, vol. 23(1), 26, 2022 |
| 2022 |
HY Huang, HY Liao, X Chen, SW Wang, CW Cheng, M Shahed-Al-Mahmud, YM Liu, A Mohapatra, TH Chen, JM Lo, YM Wu, HH Ma, YH Chang, HY Tsai, YC Chou, YP Hsueh, CY Tsai, PY Huang, SY Chang, TL Chao, HC Kao, YM Tsai, YH Chen, CY Wu, JT Jan, TJR Cheng, KI Lin*, (C Ma)*, CH Wong*, Vaccination with SARS-CoV-2 spike protein lacking glycan shields elicits enhanced protective responses in animal models, Science Translational Medicine, vol. 14, eabm0899, 2022 |
| 2022 |
KYA Huang, D Zhou, TK Tan, C Chen, HME Duyvesteyn, Y Zhao, HM Ginn, L Qin, P Rijal, L Schimanski, R Donat, A Harding, J Gilbert-Jaramillo, W James, JA Tree, K Buttigieg, M Carroll, S Charlton, CE Lien, MY Lin, CP Chen, SH Cheng, X Chen, TY Lin, EE Fry, J Ren, (C Ma, AR Townsend, DI Stuart, Structures and therapeutic potential of anti-RBD human monoclonal antibodies against SARS-CoV-2, Theranostics, vol. 12, 1-17, 2022 |
| 2022 |
Lee WH, Chen X, Liu IJ, Lee JH, Hu CM, Wu HC, Wang SK, Lee WH, (Ma C)*, Structural basis of interleukin-17B receptor in complex with a neutralizing antibody for guiding humanization and affinity maturation, Cell Reports, vol. 41(4), 111555, 2022 |
| 2022 |
Wu CY, Cheng CW, Kung CC, Liao KS, Jan JT, (Ma C, Wong CH*, Glycosite-deleted mRNA of SARS-CoV-2 spike protein as a broad-spectrum vaccine., Proceedings of the National Academy of Sciences of the United States of America, vol. 119(9), e2119995119, 2022 |
| 2022 |
Daniell H, Nair SK, Guan H, Guo Y, Kulchar RJ, Torres MDT, Shahed-Al-Mahmud M, Wakade G, Liu YM, Marques AD, Graham-Wooten J, Zhou W, Wang P, Molugu SK, de Araujo WR, de la Fuente-Nunez C, (Ma C, Short WR, Tebas P, Margulies KB, Bushman FD, Mante FK, Ricciardi RP, Collman RG, Wolff MS, Debulking different Corona (SARS-CoV-2 delta, omicron, OC43) and Influenza (H1N1, H3N2) virus strains by plant viral trap proteins in chewing gums to decrease infection and transmission., Biomaterials, vol. 288, 121671, 2022 |
| 2022 |
T Yong, KK Chang, YS Wang, (C Ma)*, Active humoral response reverts tumorigenicity through disruption of key signaling pathway, Vaccines, vol. 10, 163, 2022 |
| 2022 |
Yadav A, Ramasamy TS, Lin SC, Chen SH, （Lu J）, Liu YH, Lu FI, Hsueh YY, Lin SP, Wu CC, Autologous Platelet-Rich Growth Factor Reduces M1 Macrophages and Modulates Inflammatory Microenvironments to Promote Sciatic Nerve Regeneration., Biomedicines, vol. 10(8), 1991, 2022 |
| 2022 |
Lai PL, Ng CH, Wu CH, Lai CY, Schuyler SC, Wang V, Lin H, Lee YC, Chuang MH, Yang CH, Chen WJ, Huang HC, ( Lu J*, Development of a Chemical Cocktail That Rescues Mouse Brain Demyelination in a Cuprizone-Induced Model., Cells, vol. 11(7), 1091, 2022 |
| 2022 |
Gebreyesus, S. T., Siyal, A. A., Kitata, R. B., Chen, S.-W., Enkhbayar, B., Angata, T., (Lin, K.-I, Chen, Y.-J., Tu., S.-L., Streamlined single-cell proteomics by an integrated microfluidic chip and data-independent acquisition mass spectrometry, NATURE COMMUNICATIONS, vol. 13(1), 37, 2022 |
| 2022 |
Huang, H.-Y., Liao, H.-Y., Chen, X., Wang, S.-W., Cheng, C.-W., Shahed-Al-Mahmud, M. Chen, T.-H., Lo, J. M., Liu, Y.-M., Wu, Y.-M., Ma, H.-H., Chang, Y.-H., Tsai, H.-Y., Chou, Y.-C., Hsieh, Y.-P., Tsai, C.-Y., Huang, P.-Y., Chang, S.-Y., Chao, T.-L., Kao, H.-C., Tsai, Y.-M., Chen, Y.-H., Wu, C.-Y., Jan, J.-T., Cheng, T.-J. R., (Lin, K.-I)*, Ma, C*., Wong, C.-H.*, Vaccination with SARS-CoV-2 spike protein lacking glycan shields elicits enhanced protective responses in animal models, Science Translational Medicine, vol. 14(639):, eabm0899, 2022 |
| 2022 |
Chang, L.-Y., Liang, S.-Y., Lu, S.-C., Tseng, H.-C., Tsai, H.-Y., Tang, C.-J., Sugata, M., Chen, Y.-J., Chen, Y. -J. Wu, S.-J., (Lin, K.-I, Khoo, K.-H., Angata, T., Molecular basis and role of Siglec-7 ligand expression on chronic lymphocytic leukemia B cells, Frontiers in Immunology, vol. 13, 840388, 2022 |
